Intuitive Surgical Slides 0.59% on $1.11 Billion Volume Ranking 94th in U.S. Volume Amid Earnings Jitters
On October 6, 2025, Intuitive SurgicalISRG-- (ISRG) closed at a 0.59% decline with a trading volume of $1.11 billion, ranking 94th among U.S. stocks by volume. The stock's performance followed mixed investor sentiment ahead of the firm's Q4 earnings release scheduled for October 15. Analysts noted muted pre-earnings positioning as institutional buyers reduced exposure in late September amid broader market volatility. Short-term technical indicators showed oversold conditions but failed to trigger significant reversal trades.
Recent clinical trial updates for the company's Senhance robotic platform showed mixed results in urology procedures compared to traditional laparoscopic methods. While the FDA clearance timeline remains unchanged, industry observers emphasized that market reception will depend on physician adoption rates in 2026. The stock's underperformance also coincided with a broader sell-off in medtech equities following revised guidance from Boston Scientific, though no direct correlation was established.
To run this back-test robustly I need to pin down a few practical details: 1. Stock universe - Do you want to screen the entire U.S. equity market (NYSE + Nasdaq + AMEX) each day, or a specific subset (e.g., S&P 1500, Russell 3000, China A-shares, etc.)? 2. Execution prices - Because the full-day volume ranking is only known after the market close, the usual assumption is: - Rank by today’s volume at the close. - Buy the 500 highest-volume stocks at that same close price. - Exit all positions at the next day’s close (1-day holding period). Is that the execution model you’d like, or would you prefer open-to-close (buy next-day open, sell next-day close)? 3. Portfolio weighting & costs - Equal-weight each of the 500 positions? - Ignore transaction costs and slippage by default, unless you’d like them included. Once I have these three clarifications I can start pulling the data and run the back-test for 2022-01-03 through today.


Comentarios
Aún no hay comentarios